Overview

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

Status:
Completed
Trial end date:
2009-11-03
Target enrollment:
Participant gender:
Summary
The study will measure the early and late asthamtic response using an allergen challenge. This study will evaluate the safety and patients tolerance to repeat inhaled doses of GW870086X using a number of clinical and biological markers.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline